Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.67, No.1, p.129–136, 2020 |
||
Title: Loss of IGF2R indicates a poor prognosis and promotes cell proliferation and tumorigenesis in bladder cancer via AKT signaling pathway | ||
Author: S. B. Liu, L. B. Zhou, H. F. Wang, G. Li, Q. P. Xie, B. Hu | ||
Abstract: The insulin growth factor 2 receptor (IGF2R) belongs to insulin growth factor (IGF) pathway and has been proposed as the tumor suppressor in many cancers. However, its role in bladder cancer is unknown. In the current study, we reported that IGF2R expression was decreased in bladder cancer tissues (pd cell proliferation of bladder cancer cells in vitro and in vivo (pon level of AKT. The findings of this study indicated that IGF2R played a tumor suppressor role in bladder cancer. Downregulation IGF2R may promote tumor growth by activating AKT signaling pathway. IGF2R could be considered as a promising candidate for novel biomarker and therapeutic target for human bladder cancer. |
||
Keywords: urinary bladder neoplasms, IGF-2 receptor, AKT signaling pathway, cell proliferation | ||
Published online: 29-Jan-2020 | ||
Year: 2020, Volume: 67, Issue: 1 | Page From: 129, Page To: 136 | |
doi:10.4149/neo_2019_190206N108 |
||
|
download file |
|